Source comparison
MOTS-c Help Mitochondrial Function Research: Peptide vs NAD+ Precursor Comparison
Researchers frequently ask whether MOTS-c or NAD+ precursors (NMN, NR) better suit mitochondrial function studies. The mechanisms differ fundamentally. They're not redundant interventions. Primary Target AMPK activation → nuclear transcription NAD+ repletion →
This comparison does not assign a generated winner or score.
- Researchers frequently ask whether MOTS-c or NAD+ precursors (NMN, NR) better suit mitochondrial function studies. The mechanisms differ fundamentally. They're not redundant interventions.
- Primary Target
- AMPK activation → nuclear transcription
- NAD+ repletion → sirtuin activation
- MOTS-c acts upstream of energy sensors; NAD+ provides substrate for existing enzymes
- Glucose Uptake
- Insulin-independent GLUT4 translocation (25-40% increase)
- Minimal direct effect; improves via general metabolic efficiency
- MOTS-c superior for insulin-resistant models
- Nuclear Signaling
- Direct ARE binding, PGC-1α upregulation within 4-6 hours
- Indirect via SIRT1/3 → PGC-1α deacetylation over 24-48 hours
- MOTS-c faster transcriptional response
- Age-Related Decline
- 40-60% reduction in human muscle with age
- NAD+ levels drop 50% by age 60
- Both decline with age; MOTS-c loss more tightly linked to mitochondrial gene expression
- Research Dose Range
- 5-15 mg/kg in rodents (equivalent to 40-120 mg in 70kg human)
- 250-500 mg/day NMN equivalent in rodents
- Peptide dosing more complex due to bioavailability variables
- Outcome Timeline
- Metabolic effects 7-14 days; transcriptional changes 4-6 hours
- NAD+ repletion 1-3 days; downstream effects 2-3 weeks
- MOTS-c shows bimodal kinetics; NAD+ precursors more linear